Literature DB >> 28196864

Mechanistic understanding of N-glycosylation in Ebola virus glycoprotein maturation and function.

Bin Wang1, Yujie Wang1, Dylan A Frabutt2, Xihe Zhang2, Xiaoyu Yao1, Dan Hu1, Zhuo Zhang1, Chaonan Liu3, Shimin Zheng3, Shi-Hua Xiang4, Yong-Hui Zheng5,2.   

Abstract

The Ebola virus (EBOV) trimeric envelope glycoprotein (GP) precursors are cleaved into the receptor-binding GP1 and the fusion-mediating GP2 subunits and incorporated into virions to initiate infection. GP1 and GP2 form heterodimers that have 15 or two N-glycosylation sites (NGSs), respectively. Here we investigated the mechanism of how N-glycosylation contributes to GP expression, maturation, and function. As reported before, we found that, although GP1 NGSs are not critical, the two GP2 NGSs, Asn563 and Asn618, are essential for GP function. Further analysis uncovered that Asn563 and Asn618 regulate GP processing, demannosylation, oligomerization, and conformation. Consequently, these two NGSs are required for GP incorporation into EBOV-like particles and HIV type 1 (HIV-1) pseudovirions and determine viral transduction efficiency. Using CRISPR/Cas9 technology, we knocked out the two classical endoplasmic reticulum chaperones calnexin (CNX) and/or calreticulin (CRT) and found that both CNX and CRT increase GP expression. Nevertheless, NGSs are not required for the GP interaction with CNX or CRT. Together, we conclude that, although Asn563 and Asn618 are not required for EBOV GP expression, they synergistically regulate its maturation, which determines its functionality.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Ebola virus; calnexin; chaperone; glycoprotein; glycosylation; virus entry

Mesh:

Substances:

Year:  2017        PMID: 28196864      PMCID: PMC5392578          DOI: 10.1074/jbc.M116.768168

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Less is more: Ebola virus surface glycoprotein expression levels regulate virus production and infectivity.

Authors:  Gopi S Mohan; Ling Ye; Wenfang Li; Ana Monteiro; Xiaoqian Lin; Bishu Sapkota; Brian P Pollack; Richard W Compans; Chinglai Yang
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury.

Authors:  Z Y Yang; H J Duckers; N J Sullivan; A Sanchez; E G Nabel; G J Nabel
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

3.  Processing of the Ebola virus glycoprotein by the proprotein convertase furin.

Authors:  V E Volchkov; H Feldmann; V A Volchkova; H D Klenk
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

4.  Covalent modifications of the ebola virus glycoprotein.

Authors:  Scott A Jeffers; David Avram Sanders; Anthony Sanchez
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor.

Authors:  Jeffrey E Lee; Marnie L Fusco; Ann J Hessell; Wendelien B Oswald; Dennis R Burton; Erica Ollmann Saphire
Journal:  Nature       Date:  2008-07-10       Impact factor: 49.962

Review 6.  Roles of N-linked glycans in the endoplasmic reticulum.

Authors:  Ari Helenius; Markus Aebi
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

Review 7.  Beyond lectins: the calnexin/calreticulin chaperone system of the endoplasmic reticulum.

Authors:  David B Williams
Journal:  J Cell Sci       Date:  2006-02-15       Impact factor: 5.285

8.  Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus.

Authors:  Gopi S Mohan; Wenfang Li; Ling Ye; Richard W Compans; Chinglai Yang
Journal:  PLoS Pathog       Date:  2012-12-13       Impact factor: 6.823

Review 9.  The secret life of viral entry glycoproteins: moonlighting in immune evasion.

Authors:  Jonathan D Cook; Jeffrey E Lee
Journal:  PLoS Pathog       Date:  2013-05-16       Impact factor: 6.823

10.  A novel HIV-1 restriction factor that is biologically distinct from APOBEC3 cytidine deaminases in a human T cell line CEM.NKR.

Authors:  Tao Zhou; Yanxing Han; Ying Dang; Xiaojun Wang; Yong-Hui Zheng
Journal:  Retrovirology       Date:  2009-04-03       Impact factor: 4.602

View more
  17 in total

1.  Cysteines and N-Glycosylation Sites Conserved among All Alphaherpesviruses Regulate Membrane Fusion in Herpes Simplex Virus 1 Infection.

Authors:  Paul J F Rider; Misagh Naderi; Scott Bergeron; Vladimir N Chouljenko; Michal Brylinski; Konstantin G Kousoulas
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

2.  Innate Sensing of Influenza A Virus Hemagglutinin Glycoproteins by the Host Endoplasmic Reticulum (ER) Stress Pathway Triggers a Potent Antiviral Response via ER-Associated Protein Degradation.

Authors:  Dylan A Frabutt; Bin Wang; Sana Riaz; Richard C Schwartz; Yong-Hui Zheng
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

3.  Protein disulfide isomerases (PDIs) negatively regulate ebolavirus structural glycoprotein expression in the endoplasmic reticulum (ER) via the autophagy-lysosomal pathway.

Authors:  Bin Wang; Jing Zhang; Xin Liu; Qingqing Chai; Xiaoran Lu; Xiaoyu Yao; Zhichang Yang; Liangliang Sun; Silas F Johnson; Richard C Schwartz; Yong-Hui Zheng
Journal:  Autophagy       Date:  2022-02-07       Impact factor: 13.391

4.  Impact of Protein Glycosylation on the Design of Viral Vaccines.

Authors:  Kathleen Schön; Bernd Lepenies; Guillaume Goyette-Desjardins
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

Review 5.  CRISPR/Cas9-Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development.

Authors:  Arinze Okoli; Malachy I Okeke; Morten Tryland; Ugo Moens
Journal:  Viruses       Date:  2018-01-22       Impact factor: 5.048

Review 6.  Chaperoning the Mononegavirales: Current Knowledge and Future Directions.

Authors:  Victor Latorre; Florian Mattenberger; Ron Geller
Journal:  Viruses       Date:  2018-12-08       Impact factor: 5.048

Review 7.  Coronavirus envelope protein: current knowledge.

Authors:  Dewald Schoeman; Burtram C Fielding
Journal:  Virol J       Date:  2019-05-27       Impact factor: 4.099

8.  Global aspects of viral glycosylation.

Authors:  Ieva Bagdonaite; Hans H Wandall
Journal:  Glycobiology       Date:  2018-07-01       Impact factor: 4.313

Review 9.  The lifecycle of the Ebola virus in host cells.

Authors:  Dong-Shan Yu; Tian-Hao Weng; Xiao-Xin Wu; Frederick X C Wang; Xiang-Yun Lu; Hai-Bo Wu; Nan-Ping Wu; Lan-Juan Li; Hang-Ping Yao
Journal:  Oncotarget       Date:  2017-06-15

Review 10.  COVID-19: Drug Targets and Potential Treatments.

Authors:  Carmen Gil; Tiziana Ginex; Inés Maestro; Vanesa Nozal; Lucía Barrado-Gil; Miguel Ángel Cuesta-Geijo; Jesús Urquiza; David Ramírez; Covadonga Alonso; Nuria E Campillo; Ana Martinez
Journal:  J Med Chem       Date:  2020-06-26       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.